![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Dr. Paul Lohmann Gmbh & Co. Kgaa Emmerthal De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Sodium dihydrogen phosphate dihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2019-228 - Rev 01
This Chemical Type CEP, issued on October 04, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 194 associated with this CEP further emphasizes